Newsroom | News Archive | Publications | Contact Us for Experts  
 
Media Contact
Karen Kreeger
(215) 349-5658
Department of Communications
P: (215) 662-2560
F: (215) 349-8312
Related Links
Gene Therapy & Vaccines Seminar Series
Profile on Woo-Suk Hwang, DVM, PhD at Nature Medicine
launches in new window
University of Pennsylvania School of Medicine
University of Pennsylvania Health System

News from:

 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | RSSFeed  
 
 
    Latest Headlines
> Researchers Discover How a Small Molecule Dismantles Disease Protein Fibers
> Free Public Stem Cell Symposia, June 10, 2008
> Pay for Performance Incentives May Backfire Among Safety-Net Hospitals
 

All News Releases
 
    Media Resources
 
spacerNEWS RELEASE spacer Print Version
NOVEMBER 2, 2005
  Invitation to Cover
   
WHAT: You’re invited to a public lecture entitled, “Patient-specific human embryonic stem cells and their potential application.” This seminar is part of the Gene Therapy & Vaccines Seminar Series at the University of Pennsylvania School of Medicine.
WHO: Woo-Suk Hwang, DVM, PhD, Posco Chair Professor, Department of Theriogenology and Biotechnology, College of Veterinary Medicine, Seoul National University.

In 2004, Dr. Hwang and his research team were the first to successfully derive stem cells from a cloned human embryo. His research group also made headlines when they became the only group to clone a dog, an Afghan hound named Snuppy. Dr. Hwang most recently pledged to set up an international human stem cell repository.

WHEN & WHERE:

Monday, November 7, 2005, 4:00-5:00 PM

Harrison Auditorium
University of Pennsylvania Museum
33rd & South Streets (use 33rd street entrance).

Parking available in Lot 7 at the corner of South Street and Convention Avenue or at the Penn Tower parking garage, Civic Center Boulevard at 34th Street.

There will also be a reception prior to the lecture from 3:00-4:00 PM in the Chinese Rotunda on the 3rd floor of the Penn Museum.

Editor’s Note: Dr. Hwang’s lecture is part of the Gene Therapy & Vaccines Graduate Program of Cell and Molecular Biology and the Cell and Gene Therapy Research Affinity Group of The Children’s Hospital of Philadelphia. This seminar is sponsored in part by VGX Pharmaceuticals.

###

PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn’s School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report’s most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System comprises: its flagship hospital, the Hospital of the University of Pennsylvania, consistently rated one of the nation’s “Honor Roll” hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; Penn Presbyterian Medical Center; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home health care and hospice.

 

 


About UPHS   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

The University of Pennsylvania Health System, Philadelphia, PA 1-800-789-PENN © 2008, The Trustees of the University of Pennsylvania